Literature DB >> 27197745

Hepatocyte nuclear factor 1α-inactivated hepatocellular adenomas exhibit high (18)F-fludeoxyglucose uptake associated with glucose-6-phosphate transporter inactivation.

Kumi Ozaki1,2, Kenichi Harada3, Noboru Terayama1, Osamu Matsui2, Satoshi Saitoh4, Yoshito Tomimaru5, Takeshi Fujii6, Toshifumi Gabata2.   

Abstract

OBJECTIVE: This immunohistochemical study aimed to elucidate the molecular mechanism underlying the increased fluorine-18 fludeoxyglucose (FDG) uptake in hepatocyte nuclear factor 1α (HNF1α)-inactivated hepatocellular adenomas (H-HCAs).
METHODS: Three resected H-HCAs were studied using FDG positron emission tomography. Each maximum standardized uptake value (SUVmax) was determined. Resected samples were subjected to immunohistochemical staining for the following glucose metabolism-related proteins: glucose transporter 1 (GLUT1) and glucose transporter 2 (GLUT2), indicative of uptake and transport of glucose into cellular cytoplasm; hexokinase 2 (HK2) and hexokinase 4 (HK4), glucose phosphorylation; glucose-6-phosphate transporter 1 (G6PT1), uptake and transport of glucose-6-phosphate into endoplasmic reticulum; and glucose-6-phosphatase (G6Pase), dephosphorylation.
RESULTS: All three H-HCAs exhibited increased FDG intake, with an average SUVmax of 6.6 (range: 5.2-8.2). No sample expressed GLUT1 and HK2; all the samples exhibited equivalent GLUT2 and HK4 expression, equivalent or slightly increased G6Pase expression and significantly decreased G6PT1 expression relative to the non-neoplastic hepatocytes of background liver.
CONCLUSION: The increased FDG uptake observed in H-HCAs is associated with GLUT2 and HK4 expression and G6PT1 inactivation. ADVANCES IN KNOWLEDGE: H-HCA exhibits a high FDG uptake owing to the inactivation of G6PT1, which is transcriptionally regulated by HNF1α.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27197745      PMCID: PMC5257333          DOI: 10.1259/bjr.20160265

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  31 in total

Review 1.  Hypothesis: structures, evolution, and ancestor of glucose kinases in the hexokinase family.

Authors:  Shigeyuki Kawai; Takako Mukai; Shigetarou Mori; Bunzo Mikami; Kousaku Murata
Journal:  J Biosci Bioeng       Date:  2005-04       Impact factor: 2.894

2.  HNF1alpha inactivation promotes lipogenesis in human hepatocellular adenoma independently of SREBP-1 and carbohydrate-response element-binding protein (ChREBP) activation.

Authors:  Sandra Rebouissou; Sandrine Imbeaud; Charles Balabaud; Virginie Boulanger; Justine Bertrand-Michel; François Tercé; Charles Auffray; Paulette Bioulac-Sage; Jessica Zucman-Rossi
Journal:  J Biol Chem       Date:  2007-03-22       Impact factor: 5.157

Review 3.  Fat-containing lesions of the liver: radiologic-pathologic correlation.

Authors:  Srinivasa R Prasad; Hanlin Wang; Humberto Rosas; Christine O Menias; Vamsi R Narra; William D Middleton; Jay P Heiken
Journal:  Radiographics       Date:  2005 Mar-Apr       Impact factor: 5.333

Review 4.  Genetics and imaging of hepatocellular adenomas: 2011 update.

Authors:  Venkata S Katabathina; Christine O Menias; Alampady K P Shanbhogue; Jaishree Jagirdar; Raj Mohan Paspulati; Srinivasa R Prasad
Journal:  Radiographics       Date:  2011-10       Impact factor: 5.333

5.  GLUT1 expression in malignant tumors and its use as an immunodiagnostic marker.

Authors:  Kátia C Carvalho; Isabela W Cunha; Rafael M Rocha; Fernanda R Ayala; Mariana M Cajaíba; Maria D Begnami; Rafael S Vilela; Geise R Paiva; Rodrigo G Andrade; Fernando A Soares
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

6.  PET-avid hepatocellular adenomas: incidental findings associated with HNF1-α mutated lesions.

Authors:  Ser Yee Lee; T Peter Kingham; Maria D LaGratta; Jose Jessurun; Daniel Cherqui; William R Jarnagin; Michael D Kluger
Journal:  HPB (Oxford)       Date:  2015-12-11       Impact factor: 3.647

7.  Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience.

Authors:  Paulette Bioulac-Sage; Hervé Laumonier; Gabrielle Couchy; Brigitte Le Bail; Antonio Sa Cunha; Anne Rullier; Christophe Laurent; Jean-Frédéric Blanc; Gaelle Cubel; Hervé Trillaud; Jessica Zucman-Rossi; Charles Balabaud; Jean Saric
Journal:  Hepatology       Date:  2009-08       Impact factor: 17.425

8.  Glucose catabolism in cancer cells. Isolation, sequence, and activity of the promoter for type II hexokinase.

Authors:  S P Mathupala; A Rempel; P L Pedersen
Journal:  J Biol Chem       Date:  1995-07-14       Impact factor: 5.157

9.  Uptake of (18) FDG by a Hepatic Adenoma on Positron Emission Tomography.

Authors:  J A Stephenson; T Kapasi; O Al-Taan; A R Dennison
Journal:  Case Reports Hepatol       Date:  2011-12-22

10.  A case of multiple hepatic angiomyolipomas with high (18) F-fluorodeoxyglucose uptake.

Authors:  Soma Kumasaka; Yukiko Arisaka; Azusa Tokue; Tetsuya Higuchi; Takahito Nakajima; Yoshito Tsushima
Journal:  BMC Med Imaging       Date:  2014-05-20       Impact factor: 1.930

View more
  2 in total

Review 1.  The impact of hepatocyte nuclear factor-1α on liver malignancies and cell stemness with metabolic consequences.

Authors:  Xue Wang; Waseem Hassan; Jing Zhao; Sahar Bakht; Yunjuan Nie; Ying Wang; Qingfeng Pang; Zhaohui Huang
Journal:  Stem Cell Res Ther       Date:  2019-11-04       Impact factor: 6.832

Review 2.  FDG-PET/CT imaging findings of hepatic tumors and tumor-like lesions based on molecular background.

Authors:  Kumi Ozaki; Kenichi Harada; Noboru Terayama; Nobuyuki Kosaka; Hirohiko Kimura; Toshifumi Gabata
Journal:  Jpn J Radiol       Date:  2020-04-03       Impact factor: 2.374

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.